Minimization of drug-drug interaction risk and candidate selection in a natural product-based class of gamma-secretase modulators

被引：5
|
作者：
Hubbs, Jed L. [1 ]
Fuller, Nathan O. [1 ]
Austin, Wesley F. [1 ]
Shen, Ruichao [1 ]
Ma, Jianguo [1 ]
Gong, Zhen [2 ]
Li, Jian [2 ]
Mckee, Timothy D. [1 ]
Loureiro, Robyn M. B. [1 ]
Tate, Barbara [1 ]
Dumin, Jo Ann [1 ]
Ives, Jeffrey [1 ]
Bronk, Brian S. [1 ]
机构：
[1] Satori Pharmaceut Inc, Cambridge, MA 02139 USA
[2] WuXi AppTec Co Ltd, Shanghai 200131, Peoples R China
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2015年 / 25卷 / 07期
关键词：
Alzheimer's disease; Amyloid-beta; Gamma secretase modulator; Cytochrome P450 3A4; Sterol; Natural product; Semisynthesis; Drug-drug-interactions; OPTIMIZATION;
D O I：
10.1016/j.bmcl.2015.01.051
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
Early lead compounds in this gamma secretase modulator series were found to potently inhibit CYP3A4 and other human CYP isoforms increasing their risk of causing drug-drug-interactions (DDIs). Using structure-activity relationships and CYP3A4 structural information, analogs were developed that minimized this DDI potential. Three of these new analogs were further characterized by rat PK, rat PK/PD and rat exploratory toxicity studies resulting in selection of SPI-1865 (14) as a preclinical development candidate. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码：1621 / 1626
页数：6
相关论文
共 50 条
  • [21] Short Lecture "Ontology based ethnobotany data management to support natural product-based drug discovery"
    Ingalalli, Vijay
    Yuan, Jui-Hung
    Khederlarian, Lila
    Chandra, Sona
    Bender, Andreas
    PLANTA MEDICA, 2023, 89 (14) : 1291 - 1291
  • [22] Strategies towards expansion of chemical space of natural product-based compounds to enable drug discovery
    Silva, Daniel Gedder
    Emery, Flavio da Silva
    BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 54
  • [23] Natural product-based nanomedicines for wound healing purposes: therapeutic targets and drug delivery systems
    Hajialyani, Marziyeh
    Tewari, Devesh
    Sobarzo-Sanchez, Eduardo
    Nabavi, Seyed Mohammad
    Farzaei, Mohammad Hosein
    Abdollahi, Mohammad
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2018, 13 : 5023 - 5043
  • [24] Natural product-based drug discovery -: Epothilones as lead structures for the discovery of new anticancer agents
    Altmann, KH
    Flörsheimer, A
    Bold, G
    Caravatti, G
    Wartmann, M
    CHIMIA, 2004, 58 (10) : 686 - 690
  • [25] NPCDR: natural product-based drug combination and its disease-specific molecular regulation
    Sun, Xueni
    Zhang, Yintao
    Zhou, Ying
    Lian, Xichen
    Yan, Lili
    Pan, Ting
    Jin, Ting
    Xie, Han
    Liang, Zimao
    Qiu, Wenqi
    Wang, Jianxin
    Li, Zhaorong
    Zhu, Feng
    Sui, Xinbing
    NUCLEIC ACIDS RESEARCH, 2022, 50 (D1) : D1324 - D1333
  • [26] Exploring the Boundaries of "Practical": De Novo Syntheses of Complex Natural Product-Based Drug Candidates
    Allred, Tyler K.
    Manoni, Francesco
    Harran, Patrick G.
    CHEMICAL REVIEWS, 2017, 117 (18) : 11994 - 12051
  • [27] Utilizing Drug-Drug Interaction Prediction Tools during Drug Development: Enhanced Decision Making Based on Clinical Risk
    Shardlow, Carole E.
    Generaux, Grant T.
    MacLauchlin, Christopher C.
    Pons, Nicoletta
    Skordos, Konstantine W.
    Bloomer, Jackie C.
    DRUG METABOLISM AND DISPOSITION, 2011, 39 (11) : 2076 - 2084
  • [28] Low risk of drug-drug interactions for Ruzasvir based upon in vitro metabolism and transporter interaction studies
    Vo, Alex
    Yabut, Jocelyn
    Hafey, Michael
    Wan, Hui
    Agrawal, Nancy
    Sommadossi, Jean-Pierre
    JOURNAL OF HEPATOLOGY, 2024, 80 : S753 - S753
  • [29] Model-based assessments of CYP3A-mediated drug-drug interaction risk of milademetan
    Hong, Ying
    Ishizuka, Tomoko
    Watanabe, Akiko
    Tachibana, Masaya
    Lee, Mark
    Ishizuka, Hitoshi
    LaCreta, Frank
    Abutarif, Malaz
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2021, 14 (06): : 2220 - 2230
  • [30] Development of Natural Compound Molecular Fingerprint (NC-MFP) with the Dictionary of Natural Products (DNP) for natural product-based drug development
    Seo, Myungwon
    Shin, Hyun Kil
    Myung, Yoochan
    Hwang, Sungbo
    No, Kyoung Tai
    JOURNAL OF CHEMINFORMATICS, 2020, 12 (01)
12345